Home
Discover
Trends
Leaders
Trending Assets
Top investors this month
Trending Assets
Top investors this month
PostsTradesAbout
Statistics
Open-/-
High-/-
Low-/-
Volume-/-
Mkt Cap-/-
P/E Ratio-/-
52w High-/-
52w Low-/-
Avg Vol155.9k
Yield-/-
Beta0.55
EPS-/-
Data delayed by 15 minutes.
Categories
Health Technology
Biotechnology
About
immatics is a clinical-stage biopharmaceutical company active in the discovery and development of t-cell redirecting immunotherapies for the treatment of cancer. our transformative product candidates are - best in class - adoptive cell therapies and bispec
CEOHarpreet Singh
HQTuebingen, Baden Wuerttemberg
Employees381
Asset statistics
Commonstock is a social network that amplifies the knowledge of the best investors, verified by actual track records for signal over noise. Community members can link their existing brokerage accounts and share their real time portfolio, performance and trades (by percent only, dollar amounts never shared). Commonstock is not a brokerage, but a social layer on top of existing brokerages helping to create more engaged and informed investors.
AboutBlogCareersBrand Kit
Terms of ServiceCopyright PolicyPrivacy PolicySecurity
Already have an account?